Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Cert. of designation
Quarterly results
Auditor change
Acq. announced
Director departure
|
|
DermTech, Inc. (CNAC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/07/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/28/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 06/16/2023 |
SC 13G/A
| VAN HERK INVESTMENTS B.V. reports a 5% stake in DermTech, Inc. |
| 06/09/2023 |
4
| Wood Todd Michael (Chief Commercial Officer) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 189 shares
@ $2.53, valued at
$478.2
Sold 2,254 shares
@ $2.53, valued at
$5.7k
Sold 2,549 shares
@ $2.53, valued at
$6.4k
|
|
| 06/09/2023 |
4
| Sun Kevin M (CFO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 185 shares
@ $2.53, valued at
$468.1
Sold 2,254 shares
@ $2.53, valued at
$5.7k
Sold 2,549 shares
@ $2.53, valued at
$6.4k
Sold 2,828 shares
@ $2.61, valued at
$7.4k
|
|
| 06/09/2023 |
4
| Ibarra Claudia (COO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 140 shares
@ $2.53, valued at
$354.2
Sold 1,772 shares
@ $2.53, valued at
$4.5k
Sold 2,004 shares
@ $2.53, valued at
$5.1k
Sold 2,371 shares
@ $2.61, valued at
$6.2k
|
|
| 06/09/2023 |
4
| Akhavan Ramin (General Counsel) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 1,772 shares
@ $2.53, valued at
$4.5k
Sold 2,004 shares
@ $2.53, valued at
$5.1k
|
|
| 06/05/2023 |
4
| Collins Cynthia (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 06/05/2023 |
4
| Keraudy Nathalie Gerschtein (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 06/05/2023 |
4
| ROSENMAN HERM (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 06/05/2023 |
4
| Malloy Kirk (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 06/05/2023 |
4
| Capone Mark Christopher (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 06/05/2023 |
4
| Posard Matthew L. (Director) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 35,714 shares
@ $0 |
|
| 05/10/2023 |
4
| Christensen Bret (CEO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 500,000 options to buy
@ $2.49, valued at
$1.2M
|
|
| 05/10/2023 |
3
| Christensen Bret (CEO) has filed a Form 3 on DermTech, Inc. |
| 05/09/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/15/2023 |
4
| Wood Todd Michael (Chief Commercial Officer) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 412 shares
@ $3.26, valued at
$1.3k
|
|
| 03/15/2023 |
4
| Sun Kevin M (CFO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 514 shares
@ $3.26, valued at
$1.7k
|
|
| 03/15/2023 |
4
| Ibarra Claudia (COO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 378 shares
@ $3.26, valued at
$1.2k
|
|
| 03/13/2023 |
4
| Dobak John (CEO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Granted 56,407 shares
@ $0
Sold 1,559 shares
@ $3.26, valued at
$5.1k
|
|
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/09/2023 |
4
| Dobak John (CEO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 709 shares
@ $4.06, valued at
$2.9k
Sold 23,246 shares
@ $4.06, valued at
$94.4k
|
|
| 03/09/2023 |
4
| Wood Todd Michael (Chief Commercial Officer) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 201 shares
@ $4.06, valued at
$816.1
Sold 8,512 shares
@ $4.06, valued at
$34.6k
Granted 85,114 shares
@ $0 |
|
| 03/09/2023 |
4
| Sun Kevin M (CFO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 198 shares
@ $4.06, valued at
$803.9
Sold 8,489 shares
@ $4.06, valued at
$34.5k
Granted 85,114 shares
@ $0
Sold 3,020 shares
@ $3.88, valued at
$11.7k
|
|
| 03/09/2023 |
4
| Ibarra Claudia (COO) has filed a Form 4 on DermTech, Inc.|
Txns:
| Sold 148 shares
@ $4.06, valued at
$600.9
Sold 6,943 shares
@ $4.06, valued at
$28.2k
Granted 66,877 shares
@ $0
Sold 2,525 shares
@ $3.88, valued at
$9.8k
|
|
|
|
|